Colace and Renal failure acute - a phase IV clinical study of FDA data
Renal failure acute is found among people who take Colace, especially for people who are male, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Colace and have Renal failure acute. It is created by eHealthMe based on reports of 37,325 people who have side effects when taking Colace from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
37,325 people reported to have side effects when taking Colace.
Among them, 557 people (1.49%) have Renal failure acute.
What is Colace?
Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 37,992 Colace users for its effectiveness, alternative drugs and more.
What is Renal failure acute?
Renal failure acute (rapid kidney dysfunction) is found to be associated with 3,067 drugs and 3,063 conditions by eHealthMe.
Number of Colace and Renal failure acute reports submitted per year:
Time on Colace when people have Renal failure acute *:
Gender of people who have Renal failure acute when taking Colace*:
Age of people who have Renal failure acute when taking Colace *:
Common drugs people take besides Colace *:
Common side effects people have besides Renal failure acute *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Colace and have Renal failure acute?Check whether Renal failure acute is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How severe was Renal failure acute and when was it recovered:
Expand to all the drugs that have ingredients of docusate :
Alternative drugs to, pros and cons of Colace:
- Colace (37,992 reports)
Common Colace side effects:
- Fatigue (feeling of tiredness): 3,903 reports
- Pain: 2,917 reports
- Weakness: 2,887 reports
- Breathing difficulty: 2,745 reports
- Diarrhea: 2,555 reports
- Constipation: 2,467 reports
Browse all side effects of Colace:a b c d e f g h i j k l m n o p q r s t u v w x y z
Renal failure acute treatments and more:
- Renal failure acute (73,864 reports)
COVID vaccines that are related to Renal failure acute:
- Renal failure acute in Moderna COVID Vaccine
- Renal failure acute in Pfizer BioNTech Covid Vaccine
- Renal failure acute in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal failure acute:
- Metformin: 5,929 reports
- Aspirin: 5,823 reports
- Lasix: 5,489 reports
- Furosemide: 5,462 reports
- Lisinopril: 4,178 reports
- Simvastatin: 3,559 reports
- Omeprazole: 3,429 reports
- Prednisone: 3,314 reports
- Lopurin: 3,241 reports
- Allopurinol: 3,241 reports
All the drugs that are associated with Renal failure acute:
- Renal failure acute (3,067 drugs)
Common conditions associated with Renal failure acute:
- High blood pressure: 6,913 reports
- Type 2 diabetes: 3,046 reports
- Diabetes: 2,594 reports
- Pain: 2,373 reports
- Atrial fibrillation/flutter: 2,264 reports
- Multiple myeloma: 1,881 reports
All the conditions that are associated with Renal failure acute:
- Renal failure acute (3,063 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on docusate (the active ingredients of Colace) and Colace (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Bendamustine and Cognitive Disorder - a second ago
- Loratadine and Sinus Arrhythmia - 10 seconds ago
- Lotrimin and Proctitis Ulcerative - 14 seconds ago
- Radicava and Device Related Infection - 14 seconds ago
- Afinitor and Naprosyn drug interaction - 16 seconds ago
- Nasonex and Methylprednisolone drug interaction - 28 seconds ago
- Nesina and Glucotrol drug interaction - 38 seconds ago
- Pioglitazone and Pruritus Genital - 42 seconds ago
- Chantix and Sjogren Syndrome - 47 seconds ago
- Paresis and Muscle Spasticity - 51 seconds ago